Target intelligence / Profile preview

Eukaryotic translation initiation factor 6 (EIF6)

Target
EIF6
Molecular classification
Other (Translation initiation factor), Ribosome assembly factor
01

Overview

Eukaryotic translation initiation factor 6 (EIF6) is a highly conserved protein that plays a critical role in both ribosome biogenesis and the regulation of translation in eukaryotic cells[1][3][4]. EIF6 binds specifically to the 60S ribosomal subunit, functioning as an anti-association factor that prevents premature assembly of the 40S and 60S ribosomal subunits into the 80S ribosome[1][2][6]. In the nucleolus, EIF6 is essential for the maturation and export of the 60S pre-ribosomal subunit, whereas in the cytoplasm, it must dissociate from 60S before the ribosome can initiate translation[1][2][3]. The activity of EIF6 is regulated through post-translational modifications such as phosphorylation, with kinases like PKC involved in controlling its release from 60S, a process essential to translation initiation[7]. EIF6 is indispensable for cell growth, highly expressed in proliferative tissues, and required for tissue-specific growth and oncogene-driven transformation[1][3][4]. Disruption of EIF6 levels unbalances ribosome production and translation, with potential implications in cancer biology and metabolic regulation[4][5]. No direct drugs or small-molecule inhibitors are currently established for EIF6, and its essential cellular role limits its targetability, but its critical position in translation control and tumorigenesis has brought it increasing attention as a candidate for cancer research.

Other names
Eukaryotic initiation factor 6eIF6Integrin beta-4 binding proteinITGB4BPp27BBPCABb(2)gcnOK/SW-cl.27B4 integrin interactor
02

Biological functions

Ribosome biogenesisTranslation initiationRegulation of protein synthesisCell growthLipid and carbohydrate metabolism (via translational control of metabolic transcription factors)
03

Disease associations

CancerOncogene-driven transformationPotential link to metabolic diseases (indirect, via effect on fatty acid synthesis and glycolysis)
04

Safety considerations

Essential for cell survival; deletion is lethalOverexpression inhibits ribosome formation and protein synthesis, potentially toxic to cells

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 6 (EIF6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 6 (EIF6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call